A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus

por Chan, Owen T.M., Hannum, Lynn G., Haberman, Ann M., Madaio, Michael P., Shlomchik, Mark J.
Publicado 1999

Immunohistological Analysis of ABCD3 Expression in Caucasian and African American Prostate Tumors

por Reams, R. Renee, Jones-Triche, Jacqueline, Chan, Owen T. M., Hernandez, Brenda Y., Soliman, Karam F. A., Yates, Clayton
Publicado 2015

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT

por Kwee, Sandi A., Wong, Linda L., Hernandez, Brenda Y., Chan, Owen T.M., Sato, Miles M., Tsai, Naoky
Publicado 2015

Sphingosine kinase 1 expression enhances colon tumor growth

por Furuya, Hideki, Shimizu, Yoshiko, Tamashiro, Paulette M., Iino, Kayoko, Bielawski, Jacek, Chan, Owen T. M., Pagano, Ian, Kawamori, Toshihiko
Publicado 2017

Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer

por Rosser, Charles J., Tikhonenkov, Sergei, Nix, Jeffrey W., Chan, Owen T.M., Ianculescu, Irina, Reddy, Sandeep, Soon-Shiong, Patrick
Publicado 2021

Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model

por Furuya, Hideki, Chan, Owen T. M., Pagano, Ian, Zhu, Chengjun, Kim, Nari, Peres, Rafael, Hokutan, Kanani, Alter, Sarah, Rhode, Peter, Rosser, Charles J.
Publicado 2019

Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma

por Furuya, Hideki, Chan, Owen T.M., Hokutan, Kanani, Tsukikawa, Yutaro, Chee, Keanu, Kozai, Landon, Chan, Keith S., Dai, Yunfeng, Wong, Regan S., Rosser, Charles J.
Publicado 2019

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients

por Chan, Owen T.M., Furuya, Hideki, Pagano, Ian, Shimizu, Yoshiko, Hokutan, Kanani, Dyrskjøt, Lars, Jensen, Jørgen Bjerggaard, Malmstrom, Per-Uno, Segersten, Ulrika, Janku, Filip, Rosser, Charles J.
Publicado 2017

Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder canc...

por Furuya, Hideki, Hayashi, Kazukuni, Shimizu, Yoshiko, Kim, Nari, Tsukikawa, Yutaro, Chen, Runpu, Sun, Yijun, Chan, Owen T. M., Pagano, Ian, Peres, Rafael, Hokutan, Kanani, Igari, Fumie, Chan, Keith S., Rosser, Charles J.
Publicado 2020

Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T

por Dorff, Tanya, Hirasawa, Yosuke, Acoba, Jared, Pagano, Ian, Tamura, David, Pal, Sumanta, Zhang, Minlu, Waitz, Rebecca, Dhal, Abhilash, Haynes, Winston, Shon, John, Scholz, Mark, Furuya, Hideki, Chan, Owen T M, Huang, Jeffrey, Rosser, Charles
Publicado 2021

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity

por Furuya, Hideki, Sasaki, Yuka, Chen, Runpu, Peres, Rafael, Hokutan, Kanani, Murakami, Kaoru, Kim, Nari, Chan, Owen T. M., Pagano, Ian, Dyrskjøt, Lars, Jensen, Jørgen B., Malmstrom, Per-Uno, Segersten, Ulrika, Sun, Yijun, Arab, Abolfazl, Goodarzi, Hani, Goodison, Steve, Rosser, Charles J.
Publicado 2022